Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Benjamin

Showing results (731-740 of 920) with videos related to

Pageof 92
Sort By:
Cancer Treatment Reports|May 1, 1979
High-dose methotrexate for advanced breast cancerH Y Yap, G R Blumenschein, B S Yap, et al.
Cancer|September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylateLucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.
Melanoma Research|December 22, 1999
Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastasesO Eton, M East, S S Legha, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2001
Epithelioid sarcoma: results of conservative surgery and radiotherapyM D Callister, M T Ballo, P W Pisters, et al.
Cancer|November 1, 1994
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanomaA Buzaid, S S Legha, C M Balch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2012
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumorsAung Naing, Patricia LoRusso, Siqing Fu, et al.
American Journal of Clinical Oncology|April 30, 2021
Synovial Sarcoma of the Hand and Foot: An Institutional ReviewRiddhi R Patel, Philip J Lupo, Andrew J Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteriaHaesun Choi, Chuslip Charnsangavej, Silvana C Faria, et al.
Cancer|July 13, 2002
The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumorsLinda S Elting, Charles G Martin, Danna J Kurtin, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1995
Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowelG Gagliardi, O Kandemir, D Liu, et al.
Pageof 92

Showing results (731-740 of 920) with videos related to

Sort By:
Pageof 92
Cancer Treatment Reports|May 1, 1979
High-dose methotrexate for advanced breast cancerH Y Yap, G R Blumenschein, B S Yap, et al.
Cancer|September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylateLucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.
Melanoma Research|December 22, 1999
Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastasesO Eton, M East, S S Legha, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2001
Epithelioid sarcoma: results of conservative surgery and radiotherapyM D Callister, M T Ballo, P W Pisters, et al.
Cancer|November 1, 1994
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanomaA Buzaid, S S Legha, C M Balch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2012
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumorsAung Naing, Patricia LoRusso, Siqing Fu, et al.
American Journal of Clinical Oncology|April 30, 2021
Synovial Sarcoma of the Hand and Foot: An Institutional ReviewRiddhi R Patel, Philip J Lupo, Andrew J Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteriaHaesun Choi, Chuslip Charnsangavej, Silvana C Faria, et al.
Cancer|July 13, 2002
The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumorsLinda S Elting, Charles G Martin, Danna J Kurtin, et al.
Virchows Archiv : an International Journal of Pathology|January 1, 1995
Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowelG Gagliardi, O Kandemir, D Liu, et al.
Pageof 92